Taken together, drugs such as rifampicin, methotrexate, toosendanin, and triptolide induce liver damage through ferritinophagy- or lipophagy-dependent ferroptosis
Authorization Support : Klinic manages the authorization process, relieving you of related logistical headaches
Exenatide has been used against LNCaP, PC3, and DU145 cell lines and showed some significant effect on PCa tumor progression [78, 92]
Early-phase clinical trial data, including results from a Phase 2 randomised controlled trial published in The New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023), demonstrated significant weight reduction in adults with obesity (without type 2 diabetes), with participants receiving the highest dose losing a mean of approximately 24% of their body weight over 48 weeks